We first want to thank our world-wide readers for all that you are doing in your hospital and in your community to assist during these unprecedented times. Many of you are on the front line; your efforts are deeply appreciated. We also offer our thoughts and prayers to all the victims of this global pandemic.

In order to adapt and respond to challenges brought on by the COVID-19 pandemic, all academic journals must adjust their peer-review processes to ensure timely publication and dissemination of impactful coronavirus-related research. The Editors of *The Journal of Pediatrics* have experienced a surge of COVID-19 based submissions since late February 2020. This remarkable pace of emerging data related to COVID-19 has driven home the potential role of biomedical journals and the impact of a flood of information on journals\' submissions. This has stimulated us to adopt and revise our procedures and policies on peer review in order to rapidly triage and disseminate important information from around the world. Our goal is to accept and present as medical literature only those submissions that offer scientifically sound evidence, validly interpreted. The true importance and clinical relevance of these rapidly adjudicated manuscripts will be known at some point---as researchers and clinicians gain experience and investigates and refines these observations. In the interim we must review and publish these "rough first drafts" of COVID history.

We also encourage submissions relating to the scientific and health policy implications of the COVID-19 pandemic that are specific to infants, children, and adolescents. Following submission, the journal will immediately triage (desk review) each manuscript. Manuscripts related to COVID-19 chosen for peer review will undergo a "rapid review" process in which a dedicated group of journal editors will solicit and receive reviews within one week. Upon acceptance, the accepted and edited manuscript will be posted on the journal website. Additional submission instructions and recently published articles are available online (<https://www.jpeds.com/content/covid-19>). The Editors remain committed to publishing original research based on standards of excellence and expert review.

Two articles in this volume were handled using this expedited process---resulting in a turnaround time of three weeks from receipt of submission to publication. These two reports provide timely roadmaps for the medical community challenged by the necessity to implement new paradigms of care during the SARS-CoV-2 pandemic when faced with the urgency to save lives and protect health. Phillips et al describe a New York City children\'s hospital\'s call to arms, team approach, and experience gained in repurposing pediatric inpatient beds and providers to staff a 40-bed adult COVID-19 unit. Abrams et al describe how the COVID-19 pandemic and restrictions aimed at its mitigation can adversely affect the health of youth with a chronic health condition. They provide a thoughtful primer on optimizing novel healthcare interactions with patients with a chronic condition, with special reference in this case to asthma. Control of asthma has particularly high stakes in the COVID-19 pandemic as we learn that SARS-CoV-2 infection exacerbates asthma and that management of an exacerbation may increase the severity of COVID. Both reports are examples that people of high purpose, with good will, good leadership and teamwork can accomplish remarkable feats---inspirational and educational.
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